Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lumora developed proprietary molecular diagnostic platforms including BART and heat elution sample preparation. Their solutions enabled rapid, distributed testing for nucleic acids, proteins, and small molecules across food safety, clinical diagnostics, veterinary applications, and industrial microbiology. The company’s core technologies were licensed to major industry players before being acquired by ERBA Diagnostics Mannheim in 2015; Roche also acquired specific assets related to nucleic acid purification.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lumora.